BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22679118)

  • 1. Liver-directed therapies in patients with advanced neuroendocrine tumors.
    Jones NB; Shah MH; Bloomston M
    J Natl Compr Canc Netw; 2012 Jun; 10(6):765-74. PubMed ID: 22679118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
    Wang SC; Fidelman N; Nakakura EK
    Semin Oncol; 2013 Feb; 40(1):69-74. PubMed ID: 23391114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors.
    Kennedy AS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):193-207. PubMed ID: 26614377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
    Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
    Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients with hepatic metastases from neuroendocrine tumors.
    Clift AK; Frilling A
    Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of liver metastases in patients with digestive neuroendocrine tumors.
    Rossi RE; Massironi S; Spampatti MP; Conte D; Ciafardini C; Cavalcoli F; Peracchi M
    J Gastrointest Surg; 2012 Oct; 16(10):1981-92. PubMed ID: 22829240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the management of neuroendocrine hepatic metastases.
    Madoff DC; Gupta S; Ahrar K; Murthy R; Yao JC
    J Vasc Interv Radiol; 2006 Aug; 17(8):1235-49; quiz 1250. PubMed ID: 16923972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-directed therapies for metastatic neuroendocrine tumors.
    Garrot C; Stuart K
    Hematol Oncol Clin North Am; 2007 Jun; 21(3):545-60; ix-x. PubMed ID: 17548039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
    Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
    Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs.
    de Baere T; Deschamps F; Tselikas L; Ducreux M; Planchard D; Pearson E; Berdelou A; Leboulleux S; Elias D; Baudin E
    Eur J Endocrinol; 2015 Apr; 172(4):R151-66. PubMed ID: 25385817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
    John PK; Saif MW
    JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and complications of treating neuroendocrine metastases, embolization versus chemoembolization.
    Hartnell GG
    J Vasc Interv Radiol; 1999; 10(10):1416-7. PubMed ID: 10584661
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
    Kvols LK; Turaga KK; Strosberg J; Choi J
    J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality treatment of neuroendocrine liver metastases.
    Karabulut K; Akyildiz HY; Lance C; Aucejo F; McLennan G; Agcaoglu O; Siperstein A; Berber E
    Surgery; 2011 Aug; 150(2):316-25. PubMed ID: 21801968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for neuroendocrine liver metastases.
    Frilling A; Clift AK
    Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologically-Proven Efficacy of Bland Embolization in a Patient with Net Liver Metastasis.
    Monfardini L; Varano GM; Foà R; Della Vigna P; Bonomo G; Bertani E; Guerini-Rocco E; Spada F; Orsi F
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):948-52. PubMed ID: 26714693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Landmark Series: Neuroendocrine Tumor Liver Metastases.
    Gangi A; Howe JR
    Ann Surg Oncol; 2020 Sep; 27(9):3270-3280. PubMed ID: 32632880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of advanced neuroendocrine tumors with hepatic metastasis.
    Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
    J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management.
    Criss CR; Makary MS
    Curr Oncol; 2024 Apr; 31(4):2076-2091. PubMed ID: 38668057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.